NCT03099174 2025-06-24This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast CancerBoehringer IngelheimPhase 1 Completed133 enrolled 26 charts
NCT02117648 2019-01-07A Study of LY2835219 in Participants With CancerEli Lilly and CompanyPhase 1 Completed26 enrolled 11 charts